Multiscale simulations of biological membranes: the challenge to understand biological phenomena in a living substance

G Enkavi, M Javanainen, W Kulig, T Róg… - Chemical …, 2019 - ACS Publications
Biological membranes are tricky to investigate. They are complex in terms of molecular
composition and structure, functional over a wide range of time scales, and characterized by …

Amyloid-forming properties of human apolipoproteins: sequence analyses and structural insights

M Das, O Gursky - Lipids in Protein Misfolding, 2015 - Springer
Apolipoproteins are protein constituents of lipoproteins that transport cholesterol and fat in
circulation and are central to cardiovascular health and disease. Soluble apolipoproteins …

Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis

XR Xu, Y Wang, R Adili, L Ju, CM Spring, JW Jin… - Nature …, 2018 - nature.com
Platelet αIIbβ3 integrin and its ligands are essential for thrombosis and hemostasis, and play
key roles in myocardial infarction and stroke. Here we show that apolipoprotein A-IV (apoA …

A consensus model of human apolipoprotein AI in its monomeric and lipid-free state

JT Melchior, RG Walker, AL Cooke, J Morris… - Nature structural & …, 2017 - nature.com
Apolipoprotein (apo) AI is an organizing scaffold protein that is critical to high-density
lipoprotein (HDL) structure and metabolism, probably mediating many of its cardioprotective …

A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL [S]

AL Cooke, J Morris, JT Melchior, SE Street… - Journal of lipid …, 2018 - ASBMB
APOA1 is the most abundant protein in HDL. It modulates interactions that affect HDL'; s
cardioprotective functions, in part via its activation of the enzyme, LCAT. On nascent …

Characterization of homodimer interfaces with cross-linking mass spectrometry and isotopically labeled proteins

DB Lima, JT Melchior, J Morris, VC Barbosa… - Nature protocols, 2018 - nature.com
Cross-linking coupled with mass spectrometry (XL-MS) has emerged as a powerful strategy
for the identification of protein–protein interactions, characterization of interaction regions …

Autosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosis

T Kmochová, KO Kidd, A Orr, A Hnízda… - Kidney international, 2024 - Elsevier
Sporadic cases of apolipoprotein A-IV medullary amyloidosis have been reported. Here we
describe five families found to have autosomal dominant medullary amyloidosis due to two …

On-column trypsin digestion coupled with LC-MS/MS for quantification of apolipoproteins

CA Toth, Z Kuklenyik, JI Jones, BA Parks… - Journal of …, 2017 - Elsevier
Apolipoproteins measured in plasma or serum are potential biomarkers for assessing
metabolic irregularities that are associated with the development of cardiovascular disease …

Structural stability and local dynamics in disease-causing mutants of human apolipoprotein AI: what makes the protein amyloidogenic?

M Das, CJ Wilson, X Mei, TE Wales, JR Engen… - Journal of molecular …, 2016 - Elsevier
ApoA-I, the major protein of plasma high-density lipoprotein, removes cellular cholesterol
and protects against atherosclerosis. ApoA-I mutations can cause familial amyloidosis, a life …

Glycated apolipoprotein A-IV induces atherogenesis in patients with CAD in type 2 diabetes

Y Dai, Y Shen, QR Li, FH Ding, XQ Wang, HJ Liu… - Journal of the American …, 2017 - jacc.org
Background: Nonenzymatic glycation of apolipoproteins plays a role in the pathogenesis of
the vascular complications of diabetes. Objectives: This study investigated whether …